Founded in 2021, CanniOasis has created a theragnostic platform for the development of precision cannabinoid-based drugs that includes state-of-the-art prognostic clinical testing and molecular mapping to guide the personalized treatment of neurological disorders. A key differentiator and competitiv...See more
Headquarters:
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2021 (4 years)
Address:
3 LITTLE ROAD, #07-02, CRF BUILDING, SINGAPORE 536982
At a glanceThe company is owned by individual shareholder(s), it has no corporate shareholder.
LOW
spending power
